Log in

NASDAQ:BRKRBruker Stock Price, Forecast & News

$39.63
-1.31 (-3.20 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$39.52
Now: $39.63
$40.98
50-Day Range
$37.96
MA: $41.46
$44.53
52-Week Range
$30.78
Now: $39.63
$54.49
Volume494,100 shs
Average Volume626,653 shs
Market Capitalization$6.11 billion
P/E Ratio35.07
Dividend Yield0.39%
Beta1.38
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Read More
Bruker logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.94 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.07 billion
Cash Flow$2.02 per share
Book Value$5.96 per share

Profitability

Net Income$197.20 million

Miscellaneous

Employees7,230
Market Cap$6.11 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Bruker (NASDAQ:BRKR) Frequently Asked Questions

How has Bruker's stock been impacted by COVID-19 (Coronavirus)?

Bruker's stock was trading at $40.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BRKR shares have decreased by 0.9% and is now trading at $39.63. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Bruker?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bruker.

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Bruker.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Wednesday, May, 6th. The medical research company reported $0.14 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.22 by $0.08. The medical research company had revenue of $424 million for the quarter, compared to analyst estimates of $438.04 million. Bruker had a net margin of 8.69% and a return on equity of 25.09%. The business's quarterly revenue was down 8.1% compared to the same quarter last year. During the same period last year, the company posted $0.28 earnings per share. View Bruker's earnings history.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Wednesday, May 13th. Stockholders of record on Monday, June 1st will be given a dividend of $0.04 per share on Friday, June 19th. This represents a $0.16 annualized dividend and a yield of 0.40%. The ex-dividend date is Friday, May 29th. View Bruker's dividend history.

What price target have analysts set for BRKR?

11 brokers have issued 1-year price targets for Bruker's shares. Their forecasts range from $27.00 to $63.00. On average, they expect Bruker's stock price to reach $43.41 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View analysts' price targets for Bruker.

Has Bruker been receiving favorable news coverage?

Media coverage about BRKR stock has been trending neutral on Saturday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bruker earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news headlines about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Bruker.

Are investors shorting Bruker?

Bruker saw a decrease in short interest in June. As of June 30th, there was short interest totaling 3,070,000 shares, a decrease of 12.0% from the June 15th total of 3,490,000 shares. Based on an average daily trading volume, of 862,500 shares, the days-to-cover ratio is presently 3.6 days. Currently, 3.0% of the shares of the stock are short sold. View Bruker's Current Options Chain.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Walt Disney (DIS), Cisco Systems (CSCO), CVS Health (CVS), Alibaba Group (BABA), AbbVie (ABBV), Intel (INTC), Bank of America (BAC), Bristol-Myers Squibb (BMY), Micron Technology (MU) and AT&T (T).

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Dr. Falko Busse, Exec. Officer (Age 52)

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by many different institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.02%) and New Capital Management LP (0.00%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch. View institutional ownership trends for Bruker.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., and New Capital Management LP. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Cynthia M Friend, Marc A Kastner, and Mark Munch. View insider buying and selling activity for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $39.63.

How big of a company is Bruker?

Bruker has a market capitalization of $6.11 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.